financetom
Business
financetom
/
Business
/
Wind power developer Orsted sees 2025 core profit in line with or higher than in 2024
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Wind power developer Orsted sees 2025 core profit in line with or higher than in 2024
Feb 6, 2025 1:57 AM

COPENHAGEN (Reuters) - Orsted, the world's biggest offshore wind power developer, said on Thursday it expected core profit this year to be equal to, or above 2024, a day after cutting investment plans for coming years, sending its shares higher.

After the market close on Wednesday, the Danish company said it had decided to scale back the total amount it planned to invest for the years through 2030 by about 25% to shore up its finances in a challenging market.

It also said it saw no need to raise new cash, and that the revised plan would allow the group to keep cutting costs given it would construct at a slower pace than previously planned.

Shares in Orsted were up 6% in early trade, trimming a year-to-date fall to 8%. Sydbank analyst Jacob Pedersen said many investors had feared the company would announce a capital increase.

Offshore wind companies have faced challenges including rising costs, supply chain issues and planning delays. President Donald Trump created further uncertainty by suspending offshore wind leases on his first day in office last month.

Orsted said on Thursday most of its projects were progressing according to plan, but warned it continued to face supply chain and construction challenges at its two U.S. offshore construction projects Revolution Wind and Sunrise Wind.

Orsted said it had successfully renegotiated and settled contracts related to the closure of its Ocean Wind projects in New Jersey with a better-than-expected outcome, resulting in a net reversal of cancellation fees of 7.3 billion crowns.

The company guided for 2025 operating profit before interest, tax, depreciation, amortisation, new partnerships and cancellation fees of between 25 billion and 28 billion crowns ($3.5 billion-$3.9 billion).

The outlook matched analysts' average expectations, according to a company-provided poll.

In its full-year earnings report on Thursday, Orsted confirmed a preliminary reading for 2024 of 24.8 billion crowns.

"The year 2024 proved to be a challenging year for the industry and for Orsted," Rasmus Errboe, new CEO since Feb. 1, said in the statement. "We've experienced headwinds and have therefore taken necessary actions."

($1 = 7.1798 Danish crowns)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Kyivstar-parent VEON reports quarterly revenue growth, confirms 2025 outlook
Kyivstar-parent VEON reports quarterly revenue growth, confirms 2025 outlook
May 26, 2025
May 15 (Reuters) - VEON reported a 9% growth in its quarterly revenue on Thursday, supported by increasingly robust direct digital revenue growth. The parent of Ukraine's Kyivstar and Bangladesh's Banglalink said its revenue was $1 billion in the first quarter, with an EBITDA growth of 13.7% in reported currency to $439 million. The group confirmed its outlook for 2025....
PRESS DIGEST-British Business - May 15
PRESS DIGEST-British Business - May 15
May 26, 2025
May 15 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - GSK will buy efimosfermin, a liver disease drug in late-stage trials, for up to $2 billion from U.S. biotechnology firm Boston Pharmaceuticals, the British drugmaker said. -...
US poised to cut capital requirements for banks, FT reports
US poised to cut capital requirements for banks, FT reports
May 26, 2025
(Reuters) -Authorities in the United States are preparing to announce cuts to banks' capital requirements, the Financial Times reported on Thursday. Regulators were in the next few months poised to reduce the supplementary leverage ratio, the newspaper reported, citing several people familiar with the matter. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved